Details

Autor(en) / Beteiligte

• Zhang, Yanmei
• Hu, Qifan
• Pei, Yuquan
• Luo, Hao
• Wang, Zixuan
• Xu, Xinxin
• Zhang, Qing
• Dai, Jianli
• Wang, Qianqian
• Fan, Zilian
• Fang, Yongcong
• Ye, Min
• Li, Binhan
• Chen, Mailin
• Xue, Qi
• Zheng, Qingfeng
• Zhang, Shulin
• Huang, Miao
• Zhang, Ting
• Gu, Jin
• Xiong, Zhuo

Titel

A patient-specific lung cancer assembloid model with heterogeneous tumor microenvironments

Ist Teil von

• Nature communications, 2024-04, Vol.15 (1), p.3382-3382

Ort / Verlag

England: Nature Publishing Group

Erscheinungsjahr

2024

Link zum Volltext

Quelle

MEDLINE

Beschreibungen/Notizen

• Cancer models play critical roles in basic cancer research and precision medicine. However, current in vitro cancer models are limited by their inability to mimic the three-dimensional architecture and heterogeneous tumor microenvironments (TME) of in vivo tumors. Here, we develop an innovative patient-specific lung cancer assembloid (LCA) model by using droplet microfluidic technology based on a microinjection strategy. This method enables precise manipulation of clinical microsamples and rapid generation of LCAs with good intra-batch consistency in size and cell composition by evenly encapsulating patient tumor-derived TME cells and lung cancer organoids inside microgels. LCAs recapitulate the inter- and intratumoral heterogeneity, TME cellular diversity, and genomic and transcriptomic landscape of their parental tumors. LCA model could reconstruct the functional heterogeneity of cancer-associated fibroblasts and reflect the influence of TME on drug responses compared to cancer organoids. Notably, LCAs accurately replicate the clinical outcomes of patients, suggesting the potential of the LCA model to predict personalized treatments. Collectively, our studies provide a valuable method for precisely fabricating cancer assembloids and a promising LCA model for cancer research and personalized medicine.